BOSI, ALESSANDRO
BOSI, ALESSANDRO
Universita' degli Studi di MILANO
Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter study.
2025 B. Fattizzo, A. Marchetti, A. Bosi, C. Gurnari, J. Giannotta, G. Pedone, E. Rossi, V. Carrai, A. Guido, F. Brioschi, M. Carpenedo, M. Crugnola, D. Caramazza, L. Leuzzi, M. Marchetti, G. Merati, S. Malato, F. Vianello, A. Patriarca, H. Awada, M. Bortolotti, M. Canzi, N. Bolli, M. Capecchi, F. Chen, A. Artoni, J. Maciejewski, W. Barcellini
Severe aplastic anemia secondary to immune checkpoint inhibitor: case report and literature review
2025 A. Bosi, M.C. Di Chio, M. Bortolotti, G.A. Croci, F. Passamonti, W. Barcellini, B. Fattizzo
Natural history of chronic idiopathic neutropenia of the adult
2024 B. Fattizzo, A. Bosi, M. Sorrenti, D. Murgia, L. Pettine, M. Bortolotti, G.A. Croci, F. Passamonti, W. Barcellini
Androgen use in bone marrow failures and myeloid neoplasms: Mechanisms of action and a systematic review of clinical data
2023 A. Bosi, W. Barcellini, F. Passamonti, B. Fattizzo
Danazol Treatment for Thrombocytopenia in Myelodysplastic Syndromes: Can an "Old-fashioned" Drug be Effective?
2023 M. Riva, A. Bosi, L. Rizzo, F. Mazzon, S. Ferrari, F. Lussana, L. Borin, A. Castelli, R. Cairoli, W. Barcellini, A. Molteni, B. Fattizzo
Pulmonary embolism in a patient with eltrombopag-treated aplastic anaemia and paroxysmal nocturnal haemoglobinuria clone during COVID-19 pneumonia
2022 A. Bosi, W. Barcellini, B. Fattizzo
Clinical, Morphological and Clonal Progression of VEXAS Syndrome in the Context of Myelodysplasia Treated with Azacytidine
2022 M. Manzoni, A. Bosi, S. Fabris, M. Lionetti, S. Salerio, A.C. Migliorini, F. Cavallaro, K. Barbullushi, N. Rampi, V. Montefusco, M.G. Alessio, A. Neri, L. Baldini, M. Sciumè, E. Tagliaferri, N. Fracchiolla, N. Bolli